Ads
related to: dangers of depo provera- 2024 Update
Depo-Provera Lawsuit Update.
Check If You Qualify.
- Depo-Provera FAQ
Don't Miss Out on Depo
Provera Compensation.
- See if You Qualify
Answer Few Questions And
See If You Qualify in 3 Steps
- Take Legal Action
100% Free to Check if You
Qualify For Compensation!
- 2024 Update
Search results
Results From The WOW.Com Content Network
DMPA, under brand names such as Depo-Provera and Depo-SubQ Provera 104, is used in hormonal birth control as a long-lasting progestogen-only injectable contraceptive to prevent pregnancy in women. [ 38 ] [ 39 ] It is given by intramuscular or subcutaneous injection and forms a long-lasting depot , from which it is slowly released over a period ...
Medroxyprogesterone acetate (brand names Depo-Provera, Provera, Depo-subQ Provera 104) [4] – 150 mg (intramuscularly) or 104 mg (subcutaneously) every 3 months [3] Norethisterone enanthate (brand names NET EN, Noristerat, Norigest, Doryxas) [ 5 ] – 200 mg (intramuscularly) every 2 months [ 3 ]
Depo-Provera was clinically tested on black Rhodesian (now Zimbabwean) women in the 1970s. [1] Once approved, the drug was used as a birth control measure. Women on white-run commercial farms were coerced into accepting Depo-Provera. [5] In 1981, the drug was banned in what was by then Zimbabwe. [5]
In the late 20th century, Depo-Provera was clinically tested on Zimbabwean women. Once approved, the drug was used as a population control measure in the 1970s. Commercial farm owners put pressure on native women workers to accept the use of Depo-Provera. [78] Population control interests motivated many of the family planning programs.
Depot MPA (DMPA) and EC/MPA were developed by Upjohn in the 1960s. [12] [13] DMPA (brand name Depo-Provera) was introduced for use as a progestogen-only injectable contraceptive for the first time outside of the United States in 1969 and was subsequently approved for use in birth control in the United States in 1992.
As of November 17, 2004, the FDA has required a boxed warning on the Depo-Provera contraceptive injection, due to the risk of significant loss of bone density with long-term use. [ 8 ] In April 2005, FDA advisors requested that Pfizer place a boxed warning on their non-steroidal anti-inflammatory drug Celebrex ( celecoxib ) for cardiovascular ...
Ads
related to: dangers of depo provera